Ember Therapeutics, Knight Therapeutics deal

Ember granted Knight exclusive rights to commercialize Ember’s bone morphogenetic protein 7 ( BMP7; OP-1) pipeline in Canada, Israel, Russia and sub-Saharan Africa. The lead product has completed a P...